YAP1 and pancreatic neoplasm: Preclinical evidence supporting this concept includes the finding that YAP ablation in pancreatic cancer models reversed key immunosuppressive features, blocking MDSC recruitment, favoring antitumor macrophage polarization and T cell reactivation97.